Shares of Ocugen Inc. /zigman2/quotes/208160861/composite OCGN +5.76% slipped 2.05% to $8.13 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.43% rising 0.39% to 4,700.90 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.65% rising 0.15% to 36,142.22. This was the stock's second consecutive day of losses. Ocugen Inc. closed $10.64 below its 52-week high ($18.77), which the company reached on February 8th.
The stock underperformed when compared to some of its competitors Tuesday, as Adverum Biotechnologies Inc. /zigman2/quotes/210484271/composite ADVM +3.33% fell 0.92% to $2.15, Ocular Therapeutix Inc. /zigman2/quotes/207607068/composite OCUL +2.10% fell 0.56% to $7.04, and Kodiak Sciences Inc. /zigman2/quotes/207655028/composite KOD +5.34% rose 3.23% to $107.96. Trading volume (15.2 M) remained 22.6 million below its 50-day average volume of 37.8 M.